CANCER THERAPY Targeting drug-resistant mutations in ALK

被引：3

作者：

He, Liu ^{[1
,2
]}

Dar, Arvin C. ^{[1
,2
]}

机构：

[1] Icahn Sch Med Mt Sinai, Dept Oncol Sci, Tisch Canc Inst, Mt Sinai Ctr Therapeut Discovery, New York, NY 10029 USA

[2] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, Tisch Canc Inst, Mt Sinai Ctr Therapeut Discovery, New York, NY 10029 USA

来源：

NATURE CANCER | 2022年 / 3卷 / 06期

关键词：

INHIBITOR;

D O I：

10.1038/s43018-022-00390-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Therapy resistance limits the clinical success of tyrosine kinase inhibitors (TKIs) in ALK-positive non-small cell lung cancer. A study now proposes a framework to identify compound resistance mutations to the lorlatinib TKI and provides structure-based drug design approaches to overcome resistance mediated by ALK(G1202R) or ALK(I1171N/S/T).

引用

页码：659 / 661

页数：3

共 50 条

[31] Dodging Drug-Resistant Cancer with Diamonds
Merkel, Timothy J.
DeSimone, Joseph M.
SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (73)
[32] Predicting drug-resistant miRNAs in cancer
Kundu, Amrita
Singh, Joginder
Pal, Jayanta Kumar
Ray, Shubhra Sankar
NETWORK MODELING AND ANALYSIS IN HEALTH INFORMATICS AND BIOINFORMATICS, 2022, 12 (01):
[33] Drug-resistant cell lines in cancer
Cinatl Jr, Jindrich
Wass, Mark N.
Michaelis, Martin
NATURE COMMUNICATIONS, 2024, 15 (01)
[34] Proteomics of drug-resistant cancer biomarkers
Dong, Yalin
Cai, Jiangxia
Chen, Siying
BIOANALYSIS, 2014, 6 (19) : 2519 - 2521
[35] Targeting integrins in drug-resistant acute myeloid leukaemia
Ogana, Heather A.
Hurwitz, Samantha
Wei, Nathan
Lee, Eliana
Morris, Kayla
Parikh, Karina
Kim, Yong-Mi
BRITISH JOURNAL OF PHARMACOLOGY, 2024, 181 (02) : 295 - 316
[36] Predicting drug-resistant miRNAs in cancer
Amrita Kundu
Joginder Singh
Jayanta Kumar Pal
Shubhra Sankar Ray
Network Modeling Analysis in Health Informatics and Bioinformatics, 12
[37] Development of a novel berberine-mediated mitochondria-targeting nano-platform for drug-resistant cancer therapy
Tuo, Jue
Xie, Yanqi
Song, Jia
Chen, Yizhen
Guo, Qin
Liu, Xin
Ni, Xiaomin
Xu, Dongling
Huang, Huizhi
Yin, Sheng
Zhu, Wenbo
Wu, Jun
Hu, Haiyan
JOURNAL OF MATERIALS CHEMISTRY B, 2016, 4 (42) : 6856 - 6864
[38] Cytotoxicity of 40 Egyptian plant extracts targeting mechanisms of drug-resistant cancer cells
Hegazy, Mohamed-Elamir F.
Abdelfatan, Sara
Hamed, Ahmed R.
Mohamed, Tarik A.
Elshamy, Abdelsamed A.
Saleh, Ibrahim A.
Reda, Eman H.
Abdel-Azim, Nahla S.
Shams, Khaled A.
Sakr, Mahmoud
Sugimoto, Yoshikazu
Pare, Paul W.
Efferth, Thomas
PHYTOMEDICINE, 2019, 59
[39] Adaptive Therapy and the Cost of Drug-Resistant Mutants
Wodarz, Dominik
CANCER RESEARCH, 2021, 81 (04) : 811 - 812
[40] Therapy of drug-resistant epilepsy - experimental clues
Czuczwar, Stanislaw J.
PHARMACOLOGICAL REPORTS, 2010, 62 : 20 - 20

← 1 2 3 4 5 →